Search
Search
AI Chat
Recommendation
Reviewer
PDF Analysis
Projects
Sign in

Sign in to unlock AI Chat and more features

Osimertinib with Platinum Based Chemotherapy in Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non Small Cell Lung Cancer (NSCLC)

The Medical Journal of Cairo University/˜The œMedical Journal of Cairo University

MOHAMED M. FAROUK AKL, M.D. .

Subjects
Osimertinib
Epidermal growth factor receptor
Oncology
Lung cancer
Medicine
Chemotherapy
Cancer research
Epidermal growth factor
Internal medicine
Cancer
Receptor
Erlotinib
Sustainable Development Goals (SDG)
Good health and well-being
2025
Article
Publisher

Clinical Society of Cairo University

Journal Rank

0.135

DOI

https://doi.org/10.21608/mjcu.2025.422786

Language

en

Primary Source
Osimertinib with Platinum Based Chemotherapy in Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non Small Cell Lung Cancer (NSCLC)
Primary Source

Osimertinib with Platinum Based Chemotherapy in Epidermal Growth Factor Receptor (EGFR)-Mutated Metastatic Non Small Cell Lung Cancer (NSCLC)

The Medical Journal of Cairo University/˜The œMedical Journal of Cairo University

MOHAMED M. FAROUK AKL, M.D. .

Subjects
Osimertinib
Epidermal growth factor receptor
Oncology
Lung cancer
Medicine
Chemotherapy
Cancer research
Epidermal growth factor
Internal medicine
Cancer
Receptor
Erlotinib
Sustainable Development Goals (SDG)
Good health and well-being
2025
Article
Publisher

Clinical Society of Cairo University

Journal Rank

0.135

DOI

https://doi.org/10.21608/mjcu.2025.422786

Language

en

Primary Source